Skip to main content
. 2015 Jun 3;16:51. doi: 10.1186/s10194-015-0535-3

Table 4.

Patients treating during pregnancy

Patient 1 Patient 2 Patient 3
Age: 29. Episodic Migraine with Aura. Age: 30. Chronic Migraine without aura. Age: 32. Chronic Migraine without aura.
Pre-pregnancy migraine pattern: Pre-pregnancy migraine pattern: Pre-pregnancy migraine pattern:
Frequency: 12 days/month. Duration: 0.5–1 day. Frequency: 10 days/month plus daily background pain. Frequency: 15 days/month. Duration: 1–2 days.
Treatment: Triptan and sleep. No effective treatment. Treatment: frovatriptan, Syndol (paracetamol [acetaminopheno] + codeine + doxylamine + caffeine) and Naproxen, goes to bed.
During pregnancy: During pregnancy: During pregnancy:
Frequency: 2–4 days per week, Duration of 2–3 days, severe and in bed. Estimated 90 % reduced ability to function. 16 days: acute attacks plus daily background pain. Duration: 1 day. Estimated 50 % reduced ability to function. Treatment: Dihydocodeine during the early pregnancy with partial benefit. Estimated 60 % reduced ability to function.
TMS response: 2 consecutive pulses repeated after 15 min. Consistent reduced pain severity and duration. Could return to function and did not need to go to bed. TMS response: 4 pulses per day (2 consecutive pulses repeated after 15 min). Stopped attack escalation and reduced the severity back down to a mild tolerable level within 1–2 h. Associated symptoms resolved or did not develop. TMS response: a single pulse repeated after 15–30 min; up to 4 pulses per attack. Initially combined with dihydrocodeine. Subsequently used sTMS only and could abort the attack within an hour. Associated symptoms rarely developed.